Artia Global Partners »

Avidity Biosciences Ord shares owned by Artia Global Partners

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3M 60k 72.13
2025-09-30 $4.8M 110k 43.57
2025-06-30 $983k 35k 28.40

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
BlackRock
Wellington Management Company
RA Capital Management
venBio Select Advisor
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Norges Bank Investment Management
Bellevue Group
Glazer Capital
UBS Group
Susquehanna International

View all funds holding Avidity Biosciences Ord